Keio University

Development of a Novel Neuroregenerative Drug Candidate for Improved Paralysis Outcomes in Multiple Sclerosis

A Notch Inhibitor with a Novel Mechanism of Action

Published: November 18, 2026
Office of Communications and Public Relations

Keio University

University of Illinois

Chiba University

A Notch inhibitor with a novel mechanism of action was developed by a research team comprising Professor Midori Arai, third-year doctoral student Yuki Narushima (at the time of the study), and Senior Lecturer Shun Saito from the Department of Biosciences and Informatics in the Faculty of Science and Technology at Keio University; Associate Professor Makoto Inoue from the University of Illinois Urbana-Champaign; and Professor Takayoshi Arai from the Graduate School of Science at Chiba University. The researchers demonstrated improvements in paralysis outcomes and neural regeneration in a mouse model of multiple sclerosis (MS). The findings were published online in the international journal Advanced Science (Wiley) on October 30, 2026.

For further information, please refer to the following PDF file.

Press Release (PDF)